HomeFUNDING

FUNDING

Eliaz Therapeutics is Raising Capital

The XGAL3® therapeutic apheresis device is the early-mover for the treatment of AKI. ETI has demonstrated significant survival benefits in preclinical models and their prototype device has successfully removed GAL-3 from human blood plasma.

Fidmi Medical Launches U.S. Sales of Novel Low-Profile PEG Device and Raises $2.2 Million

Fidmi Medical CEO Shahar Millis remarked, "We are truly excited to embark on the market entry phase for Fidmi. With FDA clearance and strategic collaboration with Micro-Tech, a leader in this field, we are well-positioned to make a real difference for people requiring long-term nutritional support."

Legend Capital leads ForQaly Medical’s Series B Financing

Recently, it completed its Series B fundraising led by Legend Capital, followed by CD Capital, SAIF Partners, Chengwei Chuangban and Co-win Ventures. Existing investors Lilly Asia Ventures and Kaitai Capital also participated in the funding round.

MindMaze Group Secures USD 125 Million Financing

Financing was provided by AlbaCore Capital Group, one of Europe's leading specialist investors focusing on public and private corporate credit markets.

Bisu Raises $3.2M in Seed Round, Will Collaborate With ASICS on Future Projects

"We decided to invest in Bisu because we believe its home health lab technology, which provides affordable access to actionable health data, is very innovative and has huge potential," says Hiroaki Kageyama, President of ASICS Ventures.

Twin Health Raises $140M Series C to Scale Its Groundbreaking Whole Body Digital Twin™ Service Enabling Reversal and Prevention of Chronic Metabolic Disease

The Series C funding round includes ICONIQ Growth, Sequoia Capital India, Perceptive Advisors, Corner Ventures, LTS Investments, Helena and Sofina, enabling Twin Health to scale its Whole Body Digital Twin™ service and help solve the chronic metabolic disease health crisis.

Annoviant Awarded $1.85M SBIR Phase II Grant from the National Institutes of Health

This is a continuation of the Phase I Small Business Technology Transfer (STTR) grant the company received in 2019.

CoreBone Raises $3.7 Million Investment

Commenting on the investment, CoreBone CEO Ohad Schwartz said, "This investment in CoreBone will accelerate our sales efforts in China.

Elbit Systems’ Medical Device Spin-Off, Beyeonics, Raises $36 Million

Beyeonics Surgical and Beyeonics Vision are medical technology companies that aim to interface the systems in operating rooms using augmented reality, tracking and image processing/AI platforms, providing surgeons with valuable information and decision guidance while performing automatic tasks.